Literature DB >> 2535846

Role of cysteine 41 of the A subunit of pertussis toxin.

D L Burns1, C R Manclark.   

Abstract

The 2 cysteine residues present in the A subunit of pertussis toxin form a disulfide bond in the conformation of the toxin secreted from the bacteria. Previous studies have shown that reduction of this bond is necessary for activation of the enzyme. We have found that reduction of this bond also alters the conformation of the A subunit such that it no longer readily associates with the B oligomer of the toxin, a finding which may have implications concerning the form of the toxin found within the eukaryotic cell. In addition, we have demonstrated that reduction of the disulfide bond of the purified A subunit followed by treatment with sulfhydryl-modifying reagents such as N-ethylmaleimide or 5,5'-dithiobis-(2-nitrobenzoic acid) results in inhibition of the NAD glycohydrolase activity of the protein. When a tryptic fragment of the A subunit which contains only 1 of the cysteine residues (Cys-41) of the native protein was reacted with N-ethylmaleimide, the NAD glycohydrolase activity of this fragment was substantially reduced. These data indicate that Cys-41 may be in a region of the molecule which is critical for the enzymatic activity of the toxin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535846

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.

Authors:  S M Loosmore; G R Zealey; H A Boux; S A Cockle; K Radika; R E Fahim; G J Zobrist; R K Yacoob; P C Chong; F L Yao
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  The pertussis toxin S1 subunit is a thermally unstable protein susceptible to degradation by the 20S proteasome.

Authors:  Abhay H Pande; David Moe; Maneesha Jamnadas; Suren A Tatulian; Ken Teter
Journal:  Biochemistry       Date:  2006-11-21       Impact factor: 3.162

Review 3.  Novel bacterial ADP-ribosylating toxins: structure and function.

Authors:  Nathan C Simon; Klaus Aktories; Joseph T Barbieri
Journal:  Nat Rev Microbiol       Date:  2014-07-14       Impact factor: 60.633

4.  Monoclonal antibodies that inhibit ADP-ribosyltransferase but not NAD-glycohydrolase activity of pertussis toxin.

Authors:  H R Kaslow; J D Schlotterbeck; J G Kenimer
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

5.  Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin.

Authors:  R Antoine; C Locht
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

6.  Disulfide bond of Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin is essential to maintain the ADP-ribosylating and vacuolating activities.

Authors:  Sowmya Balasubramanian; Lavanya Pandranki; Suzanna Maupin; Kumaraguruparan Ramasamy; Alexander B Taylor; Peter John Hart; Joel B Baseman; Thirumalai R Kannan
Journal:  Cell Microbiol       Date:  2019-05-09       Impact factor: 3.715

7.  Thermal Unfolding of the Pertussis Toxin S1 Subunit Facilitates Toxin Translocation to the Cytosol by the Mechanism of Endoplasmic Reticulum-Associated Degradation.

Authors:  Tuhina Banerjee; Lucia Cilenti; Michael Taylor; Adrienne Showman; Suren A Tatulian; Ken Teter
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

Review 8.  The family of bacterial ADP-ribosylating exotoxins.

Authors:  K M Krueger; J T Barbieri
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

Review 9.  Protein Toxins That Utilize Gangliosides as Host Receptors.

Authors:  Madison Zuverink; Joseph T Barbieri
Journal:  Prog Mol Biol Transl Sci       Date:  2018-03-17       Impact factor: 3.622

Review 10.  G(i/o) protein-dependent and -independent actions of Pertussis Toxin (PTX).

Authors:  Supachoke Mangmool; Hitoshi Kurose
Journal:  Toxins (Basel)       Date:  2011-07-15       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.